Catalent Completes Expansion at Singapore Clinical Supply Facility


Applied Clinical Trials

Catalent Pharma Solutions announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility. As Catalents first Asia-Pacific region facility, it has provided additional GMP space for secondary packaging, has doubled ambient storage, and quadrupled cold storage capacity.

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.